{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:17:46Z","timestamp":1778505466064,"version":"3.51.4"},"reference-count":132,"publisher":"Bentham Science Publishers Ltd.","issue":"16","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2020,12,14]]},"abstract":"<jats:sec><jats:title\/><jats:p>Beh\u00e7et\u2019s disease (BD) is presumably an autoinflammatory disease of unknown etiology for which several animal models have been described over the years. Agents and methods used for the development of these models have ranged from the herpes simplex type one virus (hsv-1) pathogen to the use of transgenic mice. Other models have also been used to investigate a possible autoimmune component. Each model possesses its own unique set of benefits and shortcomings, with no one model fully being able to recapitulate the disease phenotype. Here, we review the proposed models and provide commentary on their effectiveness and usefulness in studying the disease.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389450121666200719010425","type":"journal-article","created":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T10:38:54Z","timestamp":1595155134000},"page":"1652-1663","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Past and Present Beh\u00e7et\u2019s Disease Animal Models"],"prefix":"10.2174","volume":"21","author":[{"given":"Jermilia","family":"Charles","sequence":"first","affiliation":[{"name":"W.M. Keck Center for Transgene Research,University of Notre Dame, Notre Dame, IN 46556, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis J.","family":"Castellino","sequence":"additional","affiliation":[{"name":"W.M. Keck Center for Transgene Research,University of Notre Dame, Notre Dame, IN 46556, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria A.","family":"Ploplis","sequence":"additional","affiliation":[{"name":"W.M. Keck Center for Transgene Research,University of Notre Dame, Notre Dame, IN 46556, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.11622\/smedj.2016123","volume":"57","author":"Tan S.Y.","year":"2016","unstructured":"Tan S.Y.; Poole P.S.; Hulusi Beh\u00e7et (1889-1948): Passion for dermatology. Singapore Med J 2016,57(7),408-409","journal-title":"Singapore Med J"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6095628","author":"Soomro A.H.","year":"2019","unstructured":"Soomro A.H.; Khan E.; Noori S.; Lone M.A.; Syal Z.; Sheikh S.; Assessment of cytokine release against oral mucosal cell line culture (tr146) stimulated by neutrophil elastase associated with behcet\u2019s disease. Int J Dent 2019","journal-title":"Int J Dent"},{"key":"ref=3","first-page":"1133","volume":"48","author":"Shahram F.","year":"2019","unstructured":"Shahram F.; Kazemi J.; Mahmoudi M.; Jadali Z.; Single nucleotide polymorphisms of fcrl3 in iranian patients with behcet\u2019s disease. Iran J Public Health 2019,48(6),1133-1139","journal-title":"Iran J Public Health"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2019.20072","author":"Villiger RA","year":"2019","unstructured":"Villiger RA; Stefanski AL; Grob\u00e9ty V; Adler S; Villiger PM; Beh\u00e7et\u2019s syndrome: clinical presentation and prevalence in Switzerland. Swiss Med Wkly 2019","journal-title":"Swiss Med Wkly"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04455-w","author":"Talarico R.","year":"2019","unstructured":"Talarico R.; Elefante E.; Parma A.; Taponeco F.; Simoncini T.; Mosca M.; Sexual dysfunction in Beh\u00e7et\u2019s syndrome. Rheumatol Int 2019","journal-title":"Rheumatol Int"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5387\/fms.2019-07","volume":"65","author":"Furuya M.Y.","year":"2019","unstructured":"Furuya M.Y.; Temmoku J.; Fujita Y.; Vasculo-Beh\u00e7et disease complicated by conversion disorder diagnosed with 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography (PET\/CT). Fukushima J Med Sci 2019,65(2),55-60","journal-title":"Fukushima J Med Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.4049\/jimmunol.1801178","volume":"203","author":"Petrushkin H.","year":"2019","unstructured":"Petrushkin H.; Norman P.J.; Lougee E.; KIR3DL1\/S1 allotypes contribute differentially to the development of beh\u00e7et disease. J Immunol 2019,203(6),1629-1635","journal-title":"J Immunol"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5761392","author":"Islam S.M.S.","year":"2019","unstructured":"Islam S.M.S.; Byun H-O.; Choi B.; Sohn S.; Inhibition of cd83 alleviates systemic inflammation in herpes simplex virus type 1-induced beh\u00e7et\u2019s disease model mouse. Mediators Inflamm 2019","journal-title":"Mediators Inflamm"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3988\/jcn.2019.15.4.429","volume":"15","author":"Kim S.W.","year":"2019","unstructured":"Kim S.W.; Kim T.G.; Oh J.; Clinical and radiographic characteristics of neuro-beh\u00e7et\u2019s disease in South Korea. J Clin Neurol 2019,15(4),429-437","journal-title":"J Clin Neurol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/art.24423","volume":"61","author":"Calamia K.T.","year":"2009","unstructured":"Calamia K.T.; Wilson F.C.; Icen M.; Crowson C.S.; Gabriel S.E.; Kremers H.M.; Epidemiology and clinical characteristics of Beh\u00e7et\u2019s disease in the US: a population-based study. Arthritis Rheum 2009,61(5),600-604","journal-title":"Arthritis Rheum"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","volume":"13","author":"Davatchi F.","year":"2017","unstructured":"Davatchi F.; Chams-Davatchi C.; Shams H.; Behcet\u2019s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol 2017,13(1),57-65","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2169\/internalmedicine.2035-18","volume":"58","author":"Kirino Y.","year":"2019","unstructured":"Kirino Y.; Nakajima H.; Clinical and genetic aspects of beh\u00e7et\u2019s disease in Japan. Intern Med 2019,58(9),1199-1207","journal-title":"Intern Med"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119085","volume":"10","author":"Kappen J.H.","year":"2015","unstructured":"Kappen J.H.; Medina-Gomez C.; van Hagen P.M.; Genome-wide association study in an admixed case series reveals IL12A as a new candidate in Beh\u00e7et disease. PLoS One 2015,10(3)","journal-title":"PLoS One"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/ar2695","volume":"11","author":"Fei Y.","year":"2009","unstructured":"Fei Y.; Webb R.; Cobb B.L.; Direskeneli H.; Saruhan-Direskeneli G.; Sawalha A.H.; Identification of novel genetic susceptibility loci for Beh\u00e7et\u2019s disease using a genome-wide association study. Arthritis Res Ther 2009,11(3),R66-R6","journal-title":"Arthritis Res Ther"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Kirino Y.","year":"2013","unstructured":"Kirino Y.; Bertsias G.; Ishigatsubo Y.; Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et\u2019s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 2013,45(2),202-207","journal-title":"Nat Genet"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1136\/bjophthalmol-2017-311753","volume":"102","author":"Wu P.","year":"2018","unstructured":"Wu P.; Du L.; Hou S.; Association of LACC1, CEBPB-PTPN1, RIPK2 and ADO-EGR2 with ocular Behcet\u2019s disease in a Chinese Han population. Br J Ophthalmol 2018,102(9),1308-1314","journal-title":"Br J Ophthalmol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"39850","DOI":"10.1038\/srep39850","volume":"7","author":"Kim S.W.","year":"2017","unstructured":"Kim S.W.; Jung Y.S.; Ahn J.B.; Identification of genetic susceptibility loci for intestinal Beh\u00e7et\u2019s disease. Sci Rep 2017,7,39850","journal-title":"Sci Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5114\/reum.2018.75516","volume":"56","author":"Shenavandeh S.","year":"2018","unstructured":"Shenavandeh S.; Jahanshahi K.A.; Aflaki E.; Tavassoli A.; Frequency of HLA-B5, HLA-B51 and HLA-B27 in patients with idiopathic uveitis and Beh\u00e7et\u2019s disease: a case-control study. Reumatologia 2018,56(2),67-72","journal-title":"Reumatologia"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1086\/319681","volume":"183","author":"Sohn S.","year":"2001","unstructured":"Sohn S.; Lee E-S.; Kwon H.J.; Lee S.I.; Bang D.; Lee S.; Expression of Th2 cytokines decreases the development of and improves Beh\u00e7et\u2019s disease-like symptoms induced by herpes simplex virus in mice. J Infect Dis 2001,183(8),1180-1186","journal-title":"J Infect Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"952","DOI":"10.2340\/00015555-2127","volume":"95","author":"Zheng Z.","year":"2015","unstructured":"Zheng Z.; Sohn S.; Ahn K.J.; Bang D.; Cho S.B.; Serum reactivity against herpes simplex virus type 1 UL48 protein in Beh\u00e7et\u2019s disease patients and a Beh\u00e7et\u2019s disease-like mouse model. Acta Derm Venereol 2015,95(8),952-958","journal-title":"Acta Derm Venereol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.17554\/j.issn.2413-8223.2016.01.12","volume":"1","author":"Kaneko K.N.F.","year":"2016","unstructured":"Kaneko K.N.F.; Togashi A.; Nomura E.; Behcet\u2019s disease and related diseases -immune reactions to oralstreptococci in their pathogenesis. J Dermatological Res 2016,1(3),41-50","journal-title":"J Dermatological Res"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/595380","author":"Galeone M.","year":"2012","unstructured":"Galeone M.; Colucci R.; D\u2019Erme A.M.; Moretti S.; Lotti T.; Potential infectious etiology of beh\u00e7et\u2019s disease. Pathol Res Int 2012","journal-title":"Pathol Res Int"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/ard.2004.025726","volume":"64","author":"Rozin A.P.","year":"2005","unstructured":"Rozin A.P.; Is Behcet\u2019s syndrome associated with infection? Ann Rheum Dis 2005,64(3),513-515","journal-title":"Ann Rheum Dis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3349\/ymj.1997.38.6.444","volume":"38","author":"Kaneko F.","year":"1997","unstructured":"Kaneko F.; Oyama N.; Nishibu A.; Streptococcal infection in the pathogenesis of Beh\u00e7et\u2019s disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 1997,38(6),444-454","journal-title":"Yonsei Med J"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jaut.2017.08.002","volume":"84","author":"Lule S.","year":"2017","unstructured":"Lule S.; Colpak A.I.; Balci-Peynircioglu B.; Beh\u00e7et Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger. J Autoimmun 2017,84,87-96","journal-title":"J Autoimmun"},{"key":"ref=26","first-page":"S96","volume":"30","author":"Sohn S.","year":"2012","unstructured":"Sohn S.; Lee E.S.; Bang D.; Learning from HSV-infected mice as a model of Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 2012,30(3)(Suppl. 72),S96-S103","journal-title":"Clin Exp Rheumatol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.3390\/ijms20184544","volume":"20","author":"Nakamura T.","year":"2019","unstructured":"Nakamura T.; Shirouzu T.; Nakata K.; Yoshimura N.; Ushigome H.; The role of major histocompatibility complex in organ transplantation- donor specific anti-major histocompatibility complex antibodies analysis goes to the next stage. Int J Mol Sci 2019,20(18),4544","journal-title":"Int J Mol Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40744-018-0100-z","volume":"5","author":"Bodis G.","year":"2018","unstructured":"Bodis G.; Toth V.; Schwarting A.; Role of human leukocyte antigens (hla) in autoimmune diseases. Rheumatol Ther 2018,5(1),5-20","journal-title":"Rheumatol Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.rdc.2017.04.003","volume":"43","author":"van Drongelen V.","year":"2017","unstructured":"van Drongelen V.; Holoshitz J.; Human leukocyte antigen-disease associations in rheumatoid arthritis. Rheum Dis Clin North Am 2017,43(3),363-376","journal-title":"Rheum Dis Clin North Am"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000503142","volume":"92","author":"Goodwin G.","year":"2019","unstructured":"Goodwin G.; Type 1 diabetes mellitus and celiac disease: distinct autoimmune disorders that share common pathogenic mechanisms. Horm Res Paediatr 2019,92(5),285-292","journal-title":"Horm Res Paediatr"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.jid.2017.05.023","volume":"137","author":"Prinz J.C.","year":"2017","unstructured":"Prinz J.C.; Melanocytes: Target cells of an HLA-C*06:02-restricted autoimmune response in psoriasis. J Invest Dermatol 2017,137(10),2053-2058","journal-title":"J Invest Dermatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00251-015-0841-6","volume":"67","author":"Carapito R.","year":"2015","unstructured":"Carapito R.; Shahram F.; Michel S.; On the genetics of the Silk Route: association analysis of HLA, IL10, and IL23R-IL12RB2 regions with Beh\u00e7et\u2019s disease in an Iranian population. Immunogenetics 2015,67(5-6),289-293","journal-title":"Immunogenetics"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.humimm.2015.10.016","volume":"77","author":"Sakly K.","year":"2016","unstructured":"Sakly K.; Maatouk M.; Hammami S.; HLA-G 14 bp insertion\/deletion polymorphism and its association with sHLA-G levels in Beh\u00e7et\u2019s disease Tunisian patients. Hum Immunol 2016,77(1),90-95","journal-title":"Hum Immunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ejim.2011.12.011","volume":"23","author":"Hamzaoui A.","year":"2012","unstructured":"Hamzaoui A.; Houman M.H.; Massouadia M.; Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet\u2019s disease in Tunisian patients. Eur J Intern Med 2012,23(4),347-349","journal-title":"Eur J Intern Med"},{"key":"ref=35","first-page":"S39","volume":"28","author":"Kaburaki T.","year":"2010","unstructured":"Kaburaki T.; Takamoto M.; Numaga J.; Genetic association of HLA-A*2601 with ocular Beh\u00e7et\u2019s disease in Japanese patients. Clin Exp Rheumatol 2010,28(4)(Suppl. 60),S39-S44","journal-title":"Clin Exp Rheumatol"},{"key":"ref=36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135575","volume":"10","author":"Kongkaew S.","year":"2015","unstructured":"Kongkaew S.; Yotmanee P.; Rungrotmongkol T.; Molecular dynamics simulation reveals the selective binding of human leukocyte antigen alleles associated with beh\u00e7et\u2019s disease. PLoS One 2015,10(9)","journal-title":"PLoS One"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.semarthrit.2019.03.003","volume":"49","author":"Muruganandam M.","year":"2019","unstructured":"Muruganandam M.; Rolle N.A.; Sibbitt W.L.; Characteristics of Behcet\u2019s Disease in the American Southwest. Semin Arthritis Rheum 2019,49(2),296-302","journal-title":"Semin Arthritis Rheum"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.3389\/fimmu.2019.02755","volume":"10","author":"Casta\u00f1o-N\u00fa\u00f1ez \u00c1.","year":"2019","unstructured":"Casta\u00f1o-N\u00fa\u00f1ez \u00c1.; Montes-Cano M.A.; Garc\u00eda-Lozano J.R.; Association of functional polymorphisms of KIR3DL1\/DS1 with Beh\u00e7et\u2019s disease. Front Immunol 2019,10,2755","journal-title":"Front Immunol"},{"key":"ref=39","first-page":"22","volume":"35","author":"Adeeb F.","year":"2017","unstructured":"Adeeb F.; Ugwoke A.; Stack A.G.; Fraser A.D.; Associations of HLA-B alleles with Beh\u00e7et\u2019s disease in Ireland. Clin Exp Rheumatol 2017,35(2)(Suppl. 104),22-23","journal-title":"Clin Exp Rheumatol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1399-0039.2005.00465.x","volume":"66","author":"Hughes E.H.","year":"2005","unstructured":"Hughes E.H.; Collins R.W.; Kondeatis E.; Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet\u2019s disease in Caucasian patients. Tissue Antigens 2005,66(3),195-199","journal-title":"Tissue Antigens"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1346-8138.2010.01125.x","volume":"38","author":"Kimura T.","year":"2011","unstructured":"Kimura T.; Asano Y.; Yamamoto M.; Sugaya M.; Sato S.; Development of Beh\u00e7et\u2019s disease in a Caucasian with human leukocyte antigen B51 after immigration to Japan. J Dermatol 2011,38(6),581-584","journal-title":"J Dermatol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13075-015-0585-6","volume":"17","author":"Xavier J.M.","year":"2015","unstructured":"Xavier J.M.; Davatchi F.; Abade O.; Characterization of the major histocompatibility complex locus association with Beh\u00e7et\u2019s disease in Iran. Arthritis Res Ther 2015,17,81","journal-title":"Arthritis Res Ther"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/08820139.2018.1517364","volume":"48","author":"Elfishawi M.M.","year":"2019","unstructured":"Elfishawi M.M.; Elgengehy F.; Mossallam G.; HLA Class I in Egyptian patients with Beh\u00e7et\u2019s disease: new association with susceptibility, protection, presentation and severity of manifestations. Immunol Invest 2019,48(2),121-129","journal-title":"Immunol Invest"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0198-8859(00)00249-4","volume":"62","author":"Choukri F.","year":"2001","unstructured":"Choukri F.; Chakib A.; Himmich H.; H\u00fce S.; Caillat-Zucman S.; HLA-B*51 and B*15 alleles confer predisposition to Beh\u00e7et\u2019s disease in Moroccan patients. Hum Immunol 2001,62(2),180-185","journal-title":"Hum Immunol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4137\/CMAMD.S39879","volume":"9","author":"Al-Okaily F.","year":"2016","unstructured":"Al-Okaily F.; Al-Rashidi S.; Al-Balawi M.; Mustafa M.; Arfin M.; Al-Asmari A.; Genetic association of HLA-A*26,-A*31, and-B*51 with Behcet\u2019s disease in Saudi patients. Clin Med Insights Arthritis Musculoskelet Disord 2016,9,167-173","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"ref=46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161305","volume":"11","author":"Ortiz-Fern\u00e1ndez L.","year":"2016","unstructured":"Ortiz-Fern\u00e1ndez L.; Carmona F.D.; Montes-Cano M.A.; Genetic analysis with the immunochip platform in Beh\u00e7et disease. Identification of residues associated in the HLA class I region and new susceptibility loci. PLoS One 2016,11(8)","journal-title":"PLoS One"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1186\/ar4328","volume":"15","author":"Montes-Cano M.A.","year":"2013","unstructured":"Montes-Cano M.A.; Conde-Jald\u00f3n M.; Garc\u00eda-Lozano J.R.; HLA and non-HLA genes in Beh\u00e7et\u2019s disease: a multicentric study in the Spanish population. Arthritis Res Ther 2013,15(5),R145","journal-title":"Arthritis Res Ther"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1038\/s41598-019-40824-y","volume":"9","author":"Nakamura J.","year":"2019","unstructured":"Nakamura J.; Meguro A.; Ishii G.; The association analysis between HLA-A*26 and Beh\u00e7et\u2019s disease. Sci Rep 2019,9(1),4426","journal-title":"Sci Rep"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2019.1705538","author":"Kato H.","year":"2020","unstructured":"Kato H.; Takeuchi M.; Horita N.; HLA-A26 is a risk factor for Beh\u00e7et\u2019s disease ocular lesions. Mod Rheumatol 2020,1-5","journal-title":"Mod Rheumatol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/ar3292","volume":"13","author":"Kang E.H.","year":"2011","unstructured":"Kang E.H.; Kim J.Y.; Takeuchi F.; Associations between the HLA-A polymorphism and the clinical manifestations of Behcet\u2019s disease. Arthritis Res Ther 2011,13(2),R49","journal-title":"Arthritis Res Ther"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10384-015-0404-2","volume":"59","author":"Kuroyanagi K.","year":"2015","unstructured":"Kuroyanagi K.; Sakai T.; Kohno H.; Association between the major histocompatibility complex and clinical response to infliximab therapy in patients with Beh\u00e7et uveitis. Jpn J Ophthalmol 2015,59(6),401-408","journal-title":"Jpn J Ophthalmol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.4238\/2014.July.2.8","volume":"13","author":"Demirseren D.D.","year":"2014","unstructured":"Demirseren D.D.; Ceylan G.G.; Akoglu G.; HLA-B51 subtypes in Turkish patients with Beh\u00e7et\u2019s disease and their correlation with clinical manifestations. Genet Mol Res 2014,13(3),4788-4796","journal-title":"Genet Mol Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3904\/kjim.2016.202","volume":"33","author":"Ryu H.J.","year":"2018","unstructured":"Ryu H.J.; Seo M.R.; Choi H.J.; Baek H.J.; Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51. Korean J Intern Med (Korean Assoc Intern Med) 2018,33(5),1025-1031","journal-title":"Korean J Intern Med (Korean Assoc Intern Med)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2019.1649103","author":"Mizuki Y.","year":"2019","unstructured":"Mizuki Y.; Horita N.; Horie Y.; The influence of HLA-B51 on clinical manifestations among Japanese patients with Beh\u00e7et\u2019s disease: A nationwide survey. Mod Rheumatol 2019,1-7","journal-title":"Mod Rheumatol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/art.1780380321","volume":"38","author":"Takeno M.","year":"1995","unstructured":"Takeno M.; Kariyone A.; Yamashita N.; Excessive function of peripheral blood neutrophils from patients with Beh\u00e7et\u2019s disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995,38(3),426-433","journal-title":"Arthritis Rheum"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0923-1811(01)00086-X","volume":"26","author":"Sohn S.","year":"2001","unstructured":"Sohn S.; Lee E.S.; Lee S.; The correlation of MHC haplotype and development of Beh\u00e7et\u2019s disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci 2001,26(3),173-181","journal-title":"J Dermatol Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-2370.2004.00446.x","volume":"31","author":"Marin M.L.C.","year":"2004","unstructured":"Marin M.L.C.; Savioli C.R.; Yamamoto J.H.; Kalil J.; Goldberg A.C.; MICA polymorphism in a sample of the S\u00e3o Paulo population, Brazil. Eur J Immunogenet 2004,31(2),63-71","journal-title":"Eur J Immunogenet"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1034\/j.1399-0039.2003.00014.x","volume":"61","author":"Nomura E.","year":"2003","unstructured":"Nomura E.; Sato M.; Suemizu H.; Hyperkeratosis and leukocytosis in transgenic mice carrying MHC class I chain-related gene B (MICB). Tissue Antigens 2003,61(4),300-307","journal-title":"Tissue Antigens"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"21033","DOI":"10.1038\/srep21033","volume":"6","author":"Zhang J.","year":"2016","unstructured":"Zhang J.; Liao D.; Yang L.; Hou S.; Association between Functional MICA-TM and Behcet\u2019s Disease: A Systematic Review and Meta-analysis. Sci Rep 2016,6,21033","journal-title":"Sci Rep"},{"key":"ref=60","first-page":"1921","volume":"40","author":"Yabuki K.","year":"1999","unstructured":"Yabuki K.; Mizuki N.; Ota M.; Association of MICA gene and HLA-B*5101 with Beh\u00e7et\u2019s disease in Greece. Invest Ophthalmol Vis Sci 1999,40(9),1921-1926","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=61","author":"\u00c7olpak A.I.","year":"2014","unstructured":"\u00c7olpak A.I.; \u00d6zdemir Y.G.; Kalyoncu U.; The presence of autoantibodies against vascular and nervous tissue in sera from patients with neuro-beh\u00e7et\u2019s disease 2014","journal-title":"The presence of autoantibodies against vascular and nervous tissue in sera from patients with neuro-beh\u00e7et\u2019s disease"},{"key":"ref=62","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/956837","author":"Cebeci F.","year":"2013","unstructured":"Cebeci F.; Onsun N.; Pekdemir A.; Uras A.R.; Kayata\u015f K.; Thyroid autoimmunity and Beh\u00e7et\u2019s disease: is there a significant association? ScientificWorldJournal 2013","journal-title":"ScientificWorldJournal"},{"key":"ref=63","first-page":"133","volume":"15","author":"Hussain M","year":"2018","unstructured":"Hussain M; Xiao J; Zhang Y; Chen P; Du H.; Identification of hnRNP C1\/C2 as an Autoantigen in Patients with Behcet\u2019s Disease Iran J Immunol 2018,15(2),133-141","journal-title":"Iran J Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4246965","author":"Puccetti A.","year":"2018","unstructured":"Puccetti A.; Fiore P.F.; Pelosi A.; Gene expression profiling in behcet\u2019s disease indicates an autoimmune component in the pathogenesis of the disease and opens new avenues for targeted therapy. J Immunol Res 2018","journal-title":"J Immunol Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1046\/j.1365-2249.1998.00620.x","volume":"113","author":"Ta\u015f\u00e7i B.","year":"1998","unstructured":"Ta\u015f\u00e7i B.; Direskeneli H.; Serdaro\u01f5lu P.; Akman-Demir G.; Eraksoy M.; Saruhan-Direskeneli G.; Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Beh\u00e7et patients. Clin Exp Immunol 1998,113(1),100-104","journal-title":"Clin Exp Immunol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/1521-4141(200202)32:2<356:AID-IMMU356>3.0.CO;2-9","volume":"32","author":"Mor F.","year":"2002","unstructured":"Mor F.; Weinberger A.; Cohen I.R.; Identification of alpha-tropomyosin as a target self-antigen in Beh\u00e7et\u2019s syndrome. Eur J Immunol 2002,32(2),356-365","journal-title":"Eur J Immunol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-3-319-49674-0_9","volume":"82","author":"Hitchcock-DeGregori S.E.","year":"2017","unstructured":"Hitchcock-DeGregori S.E.; Barua B.; Tropomyosin structure, function, and interactions: A dynamic regulator. Subcell Biochem 2017,82,253-284","journal-title":"Subcell Biochem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1242\/jcs.172502","volume":"128","author":"Gunning P.W.","year":"2015","unstructured":"Gunning P.W.; Hardeman E.C.; Lappalainen P.; Mulvihill D.P.; Tropomyosin - master regulator of actin filament function in the cytoskeleton. J Cell Sci 2015,128(16),2965-2974","journal-title":"J Cell Sci"},{"key":"ref=69","first-page":"255","volume":"318","author":"Khaitlina S.Y.","year":"2015","unstructured":"Khaitlina S.Y.; Chapter Seven - Tropomyosin as a Regulator of Actin DynamicsK W B T-I R of C and M B Jeon, Ed. Academic Press 2015,318,255-291"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.mehy.2006.12.060","volume":"69","author":"Mikita C.P.","year":"2007","unstructured":"Mikita C.P.; Padlan E.A.; Why is there a greater incidence of allergy to the tropomyosin of certain animals than to that of others? Med Hypotheses 2007,69(5),1070-1073","journal-title":"Med Hypotheses"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/all.13115","volume":"72","author":"Faber M.A.","year":"2017","unstructured":"Faber M.A.; Pascal M.; El Kharbouchi O.; Shellfish allergens: tropomyosin and beyond. Allergy 2017,72(6),842-848","journal-title":"Allergy"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1097\/01.mib.0000231573.65935.67","volume":"12","author":"Mirza Z.K.","year":"2006","unstructured":"Mirza Z.K.; Sastri B.; Lin J.J.C.; Amenta P.S.; Das K.M.; Autoimmunity against human tropomyosin isoforms in ulcerative colitis: localization of specific human tropomyosin isoforms in the intestine and extraintestinal organs. Inflamm Bowel Dis 2006,12(11),1036-1043","journal-title":"Inflamm Bowel Dis"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.febslet.2005.02.073","volume":"579","author":"Kovvali G.","year":"2005","unstructured":"Kovvali G.; Das K.M.; Molecular mimicry may contribute to pathogenesis of ulcerative colitis. FEBS Lett 2005,579(11),2261-2266","journal-title":"FEBS Lett"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2230.2001.00852.x","volume":"26","author":"Powell A.M.","year":"2001","unstructured":"Powell A.M.; Black M.M.; Epitope spreading: protection from pathogens, but propagation of autoimmunity? Clin Exp Dermatol 2001,26(5),427-433","journal-title":"Clin Exp Dermatol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri724","volume":"2","author":"Vanderlugt C.L.","year":"2002","unstructured":"Vanderlugt C.L.; Miller S.D.; Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2002,2(2),85-95","journal-title":"Nat Rev Immunol"},{"key":"ref=76","first-page":"S86","volume":"25","author":"Baharav E.","year":"2007","unstructured":"Baharav E.; Mor F.; Halpern M.; Quintana F.; Weinberger A.; Tropomyosin-induced arthritis in rats. Clin Exp Rheumatol 2007,25(4)(Suppl. 45),S86-S92","journal-title":"Clin Exp Rheumatol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1529-8019.2007.00138.x","volume":"20","author":"Jackson J.M.","year":"2007","unstructured":"Jackson J.M.; TNF- \u03b1 inhibitors. Dermatol Ther 2007,20(4),251-264","journal-title":"Dermatol Ther"},{"key":"ref=78","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/385297","author":"Umare V.","year":"2014","unstructured":"Umare V.; Pradhan V.; Nadkar M.; Effect of proinflammatory cytokines (IL-6, TNF-\u03b1, and IL-1\u03b2) on clinical manifestations in Indian SLE patients. Mediators Inflamm 2014","journal-title":"Mediators Inflamm"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1365-2249.2005.02760.x","volume":"140","author":"Mahesh S.P.","year":"2005","unstructured":"Mahesh S.P.; Li Z.; Buggage R.; Alpha tropomyosin as a self-antigen in patients with Beh\u00e7et\u2019s disease. Clin Exp Immunol 2005,140(2),368-375","journal-title":"Clin Exp Immunol"},{"key":"ref=80","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.ima01ts58","author":"Li Z","unstructured":"Li Z; Srivastava P.; Heat\u2010shock proteins. Curr Protoc Immunol 2003; 2: Appendix 1:Appendix 1T","journal-title":"Curr Protoc Immunol 2003; 2: Appendix 1:Appendix 1T"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3389\/fnins.2018.00821","volume":"12","author":"Miller D.J.","year":"2018","unstructured":"Miller D.J.; Fort P.E.; Heat shock proteins regulatory role in neurodevelopment. Front Neurosci 2018,12,821","journal-title":"Front Neurosci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1242\/jcs.01284","volume":"117","author":"Beere H.M.","year":"2004","unstructured":"Beere H.M.; \u201cThe stress of dying\u201d: the role of heat shock proteins in the regulation of apoptosis. J Cell Sci 2004,117(Pt 13),2641-2651","journal-title":"J Cell Sci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1006\/rwgn.2001.0588","author":"Candido E.P.M.","year":"2001","unstructured":"Candido E.P.M.; Heat Shock Proteins S Brenner and J H B T-E of G Miller, Eds. New York: Academic Press 2001,914-915"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3389\/fphar.2019.00920","volume":"10","author":"Dukay B.","year":"2019","unstructured":"Dukay B.; Csoboz B.; T\u00f3th M.E.; Heat-shock proteins in neuroinflammation. Front Pharmacol 2019,10,920","journal-title":"Front Pharmacol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"BE01","DOI":"10.7860\/JCDR\/2016\/14568.7444","volume":"10","author":"Maleki F.","year":"2016","unstructured":"Maleki F.; Khosravi A.; Nasser A.; Taghinejad H.; Azizian M.; Bacterial heat shock protein activity. J Clin Diagn Res 2016,10(3),BE01-BE03","journal-title":"J Clin Diagn Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1128\/CMR.12.1.19","volume":"12","author":"Z\u00fcgel U.","year":"1999","unstructured":"Z\u00fcgel U.; Kaufmann S.H.E.; Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 1999,12(1),19-39","journal-title":"Clin Microbiol Rev"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00438-008-0417-3","volume":"281","author":"Singh B.","year":"2009","unstructured":"Singh B.; Gupta R.S.; Conserved inserts in the Hsp60 (GroEL) and Hsp70 (DnaK) proteins are essential for cellular growth. Mol Genet Genomics 2009,281(4),361-373","journal-title":"Mol Genet Genomics"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1099\/jmm.0.064857-0","volume":"62","author":"Urban-Chmiel R.","year":"2013","unstructured":"Urban-Chmiel R.; Dec M.; Puchalski A.; Wernicki A.; Characterization of heat-shock proteins in Escherichia coli strains under thermal stress in vitro. J Med Microbiol 2013,62(Pt 12),1897-1901","journal-title":"J Med Microbiol"},{"key":"ref=89","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/621417","author":"Moudgil K.D.","year":"2013","unstructured":"Moudgil K.D.; Thompson S.J.; Geraci F.; De Paepe B.; Shoenfeld Y.; Heat-shock proteins in autoimmunity. Autoimmune Dis 2013","journal-title":"Autoimmune Dis"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"317","DOI":"10.5114\/ceji.2016.63133","volume":"41","author":"Koli\u0144ski T.","year":"2016","unstructured":"Koli\u0144ski T.; Marek-Trzonkowska N.; Trzonkowski P.; Siebert J.; Heat shock proteins (HSPs) in the homeostasis of regulatory T cells (Tregs). Cent Eur J Immunol 2016,41(3),317-323","journal-title":"Cent Eur J Immunol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s12192-014-0507-6","volume":"19","author":"Kasperkiewicz M.","year":"2014","unstructured":"Kasperkiewicz M.; Tukaj S.; Gembicki A.J.; Evidence for a role of autoantibodies to heat shock protein 60, 70, and 90 in patients with dermatitis herpetiformis. Cell Stress Chaperones 2014,19(6),837-843","journal-title":"Cell Stress Chaperones"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.compbiomed.2012.08.009","volume":"42","author":"Ghasemi Y.","year":"2012","unstructured":"Ghasemi Y.; Dabbagh F.; Rasoul-Amini S.; Borhani Haghighi A.; Morowvat M.H.; The possible role of HSPs on Beh\u00e7et\u2019s disease: a bioinformatic approach. Comput Biol Med 2012,42(11),1079-1085","journal-title":"Comput Biol Med"},{"key":"ref=93","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/249157","author":"Direskeneli H.","year":"2013","unstructured":"Direskeneli H.; Innate and Adaptive Responses to Heat Shock Proteins in Behcet\u2019s Disease. Genet Res Int 2013","journal-title":"Genet Res Int"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2444:AID-IMMU2444>3.0.CO;2-N","volume":"28","author":"Hu W.","year":"1998","unstructured":"Hu W.; Hasan A.; Wilson A.; Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol 1998,28(8),2444-2455","journal-title":"Eur J Immunol"},{"key":"ref=95","first-page":"S28","volume":"29","author":"Shahram F.","year":"2011","unstructured":"Shahram F.; Nikoopour E.; Rezaei N.; Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behcet\u2019s disease. Clin Exp Rheumatol 2011,29(4)(Suppl. 67),S28-S31","journal-title":"Clin Exp Rheumatol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3389\/fimmu.2017.01599","volume":"8","author":"van Eden W.","year":"2017","unstructured":"van Eden W.; Jansen M.A.A.; Ludwig I.; van Kooten P.; van der Zee R.; Broere F.; The enigma of heat shock proteins in immune tolerance. Front Immunol 2017,8,1599","journal-title":"Front Immunol"},{"key":"ref=97","first-page":"53","volume":"109","author":"Petris C.K.","year":"2012","unstructured":"Petris C.K.; Almony A.; Ophthalmic manifestations of rheumatologic disease: diagnosis and management. Mo Med 2012,109(1),53-58","journal-title":"Mo Med"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/0301-4738.156914","volume":"63","author":"Bansal S.","year":"2015","unstructured":"Bansal S.; Barathi V.A.; Iwata D.; Agrawal R.; Experimental autoimmune uveitis and other animal models of uveitis: An update. Indian J Ophthalmol 2015,63(3),211-218","journal-title":"Indian J Ophthalmol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0896-8411(90)90144-H","volume":"3","author":"Chan C.C.","year":"1990","unstructured":"Chan C.C.; Caspi R.R.; Ni M.; Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun 1990,3(3),247-255","journal-title":"J Autoimmun"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.140.5.1490","volume":"140","author":"Caspi R.R.","year":"1988","unstructured":"Caspi R.R.; Roberge F.G.; Chan C.C.; A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 1988,140(5),1490-1495","journal-title":"J Immunol"},{"key":"ref=101","first-page":"3342","volume":"35","author":"Gery I.","year":"1994","unstructured":"Gery I.; Chanaud N.P.; Anglade E.; Recoverin is highly uveitogenic in Lewis rats. Invest Ophthalmol Vis Sci 1994,35(8),3342-3345","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.2988124","volume":"228","author":"Pfister C.","year":"1985","unstructured":"Pfister C.; Chabre M.; Plouet J.; Retinal S antigen identified as the 48K protein regulating light-dependent phosphodiesterase in rods. Science 1985,228(4701),891-893","journal-title":"Science"},{"key":"ref=103","first-page":"3233","volume":"42","author":"de Smet M.D.","year":"2001","unstructured":"de Smet M.D.; Bitar G.; Mainigi S.; Nussenblatt R.B.; Human S-antigen determinant recognition in uveitis. Invest Ophthalmol Vis Sci 2001,42(13),3233-3238","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/art.1780300307","volume":"30","author":"Petty R.E.","year":"1987","unstructured":"Petty R.E.; Hunt D.W.C.; Rollins D.F.; Schroeder M-L.; Puterman M.L.; Immunity to soluble retinal antigen in patients with uveitis accompanying juvenile rheumatoid arthritis. Arthritis Rheum 1987,30(3),287-293","journal-title":"Arthritis Rheum"},{"key":"ref=105","first-page":"259","volume":"77","author":"Hamzaoui K.","year":"1999","unstructured":"Hamzaoui K.; Boussen E.; Gorgi Y.; Ouertani A.; Ayed K.; Molecular mimicry between S-Antigen and viral peptides | Mimetisme moleculaire entre l\u2019antigene-s et les peptides viraux. Tunis Med 1999,77(5),259-263","journal-title":"Tunis Med"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/bjo.77.9.584","volume":"77","author":"Yamamoto J.H.","year":"1993","unstructured":"Yamamoto J.H.; Minami M.; Inaba G.; Masuda K.; Mochizuki M.; Cellular autoimmunity to retinal specific antigens in patients with Beh\u00e7et\u2019s disease. Br J Ophthalmol 1993,77(9),584-589","journal-title":"Br J Ophthalmol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s8755-9668(86)80005-9","volume":"2","author":"Yamada M.","year":"1986","unstructured":"Yamada M.; Shichi H.; Yuasa T.; Tanouchi Y.; Mimura Y.; Superoxide in ocular inflammation: Human and experimental uveitis. Adv Free Radic Biol Med 1986,2(2),111-117","journal-title":"Adv Free Radic Biol Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1136\/bjo.78.12.927","volume":"78","author":"Yamamoto J.H.","year":"1994","unstructured":"Yamamoto J.H.; Fujino Y.; Lin C.; Nieda M.; Juji T.; Masuda K.; S-antigen specific T cell clones from a patient with Beh\u00e7et\u2019s disease. Br J Ophthalmol 1994,78(12),927-932","journal-title":"Br J Ophthalmol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1167\/iovs.09-4313","volume":"51","author":"Takeuchi M.","year":"2010","unstructured":"Takeuchi M.; Usui Y.; Okunuki Y.; Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet\u2019s patients with uveitis. Invest Ophthalmol Vis Sci 2010,51(6),3067-3075","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10072-017-2856-2","volume":"38","author":"Erda\u011f E.","year":"2017","unstructured":"Erda\u011f E.; \u015eahin C.; K\u00fc\u00e7\u00fckali C.\u0130.; Effects of in vivo and in vitro administration of neuro-Behcet\u2019s disease IgG. Neurol Sci 2017,38(5),833-843","journal-title":"Neurol Sci"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"Sakane T.","year":"1999","unstructured":"Sakane T.; Takeno M.; Suzuki N.; Inaba G.; Beh\u00e7et\u2019s disease. N Engl J Med 1999,341(17),1284-1291","journal-title":"N Engl J Med"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fcimb.2019.00127","volume":"9","author":"Tognarelli E.I.","year":"2019","unstructured":"Tognarelli E.I.; Palomino T.F.; Corrales N.; Bueno S.M.; Kalergis A.M.; Gonz\u00e1lez P.A.; Herpes simplex virus evasion of early host antiviral responses. Front Cell Infect Microbiol 2019,9,127","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/BF02030511","volume":"9","author":"Hamza M.","year":"1990","unstructured":"Hamza M.; Elleuch M.; Slim A.; Hamzaoui K.; Ayed K.; Antibodies to herpes simplex virus in patients with Beh\u00e7et\u2019s disease. Clin Rheumatol 1990,9(4),498-500","journal-title":"Clin Rheumatol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF02505221","volume":"288","author":"Lee S.","year":"1996","unstructured":"Lee S.; Bang D.; Cho Y.H.; Lee E.S.; Sohn S.; Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Beh\u00e7et\u2019s disease. Arch Dermatol Res 1996,288(4),179-183","journal-title":"Arch Dermatol Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/00015550310007472","volume":"83","author":"Tojo M.","year":"2003","unstructured":"Tojo M.; Zheng X.; Yanagihori H.; Detection of herpes virus genomes in skin lesions from patients with Beh\u00e7et\u2019s disease and other related inflammatory diseases. Acta Derm Venereol 2003,83(2),124-127","journal-title":"Acta Derm Venereol"},{"key":"ref=116","first-page":"21","volume":"8","author":"Sohn S.","year":"1998","unstructured":"Sohn S.; Lee E.S.; Bang D.; Lee S.; Beh\u00e7et\u2019s disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 1998,8(1),21-23","journal-title":"Eur J Dermatol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.imbio.2011.11.002","volume":"217","author":"Shim J.A.","year":"2012","unstructured":"Shim J.A.; Park S.; Lee E.S.; Niki T.; Hirashima M.; Sohn S.; Galectin-9 ameliorates herpes simplex virus-induced inflammation through apoptosis. Immunobiology 2012,217(6),657-666","journal-title":"Immunobiology"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jdermsci.2008.05.001","volume":"52","author":"Choi B.","year":"2008","unstructured":"Choi B.; Hwang Y.; Kwon H.J.; Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model. J Dermatol Sci 2008,52(2),87-97","journal-title":"J Dermatol Sci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2011.01.062","volume":"657","author":"Choi B.","year":"2011","unstructured":"Choi B.; Kim J.; Lee E.S.; Bang D.; Sohn S.; Synthesized pyridine compound derivatives decreased TNF alpha and adhesion molecules and ameliorated HSV-induced inflammation in a mouse model. Eur J Pharmacol 2011,657(1-3),167-172","journal-title":"Eur J Pharmacol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/gt.2008.180","volume":"16","author":"Shim J.","year":"2009","unstructured":"Shim J.; Byun H.O.; Lee Y.D.; Lee E.S.; Sohn S.; Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet\u2019s disease-like mouse model. Gene Ther 2009,16(3),415-425","journal-title":"Gene Ther"},{"key":"ref=121","first-page":"S13","volume":"29","author":"Choi B.","year":"2011","unstructured":"Choi B.; Lee E.S.; Sohn S.; Vitamin D3 ameliorates herpes simplex virus-induced Beh\u00e7et\u2019s disease-like inflammation in a mouse model through down-regulation of Toll-like receptors. Clin Exp Rheumatol 2011,29(4)(Suppl. 67),S13-S19","journal-title":"Clin Exp Rheumatol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1046\/j.1365-2133.2001.04498.x","volume":"145","author":"Sohn S.","year":"2001","unstructured":"Sohn S.; Bang D.; Lee E.S.; Kwon H.J.; Lee S.I.; Lee S.; Experimental studies on the antiviral agent famciclovir in Beh\u00e7et\u2019s disease symptoms in ICR mice. Br J Dermatol 2001,145(5),799-804","journal-title":"Br J Dermatol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.imbio.2013.03.005","volume":"218","author":"Choi J.","year":"2013","unstructured":"Choi J.; Lee E.S.; Choi B.; Sohn S.; Therapeutic potency of Poly I:C in HSV-induced inflammation through up-regulation of IL-15 receptor alpha. Immunobiology 2013,218(9),1119-1130","journal-title":"Immunobiology"},{"key":"ref=124","first-page":"54","volume":"27","author":"Kang S.","year":"2009","unstructured":"Kang S.; Lee E.S.; Choi B.; Effects of irradiation on cytokine production in a mouse model of Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 2009,27(1),54-63","journal-title":"Clin Exp Rheumatol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.0906-6705.2004.00210.x","volume":"13","author":"Sohn S.","year":"2004","unstructured":"Sohn S.; Lutz M.; Kwon H.J.; Konwalinka G.; Lee S.; Schirmer M.; Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades-Beh\u00e7et\u2019s disease-like mouse model. Exp Dermatol 2004,13(10),630-634","journal-title":"Exp Dermatol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.3390\/ijms16047413","volume":"16","author":"Choi B.","year":"2015","unstructured":"Choi B.; Kim H.A.; Suh C.H.; Byun H.O.; Jung J.Y.; Sohn S.; The relevance of miRNA-21 in HSV-induced inflammation in a mouse model. Int J Mol Sci 2015,16(4),7413-7427","journal-title":"Int J Mol Sci"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jdermsci.2013.11.001","volume":"73","author":"Anower A.K.M.M.","year":"2014","unstructured":"Anower A.K.M.M.; Shim J.A.; Choi B.; Kwon H.J.; Sohn S.; The role of classical and alternative macrophages in the immunopathogenesis of herpes simplex virus-induced inflammation in a mouse model. J Dermatol Sci 2014,73(3),198-208","journal-title":"J Dermatol Sci"},{"key":"ref=128","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/903948","author":"Shim J.A.","year":"2013","unstructured":"Shim J.A.; Lee E.S.; Choi B.; Sohn S.; The role of T cell immunoglobulin mucin domains 1 and 4 in a herpes simplex virus-induced Beh\u00e7et\u2019s disease mouse model. Mediators Inflamm 2013","journal-title":"Mediators Inflamm"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00403-004-0498-8","volume":"296","author":"Lee E.S.","year":"2004","unstructured":"Lee E.S.; Kim Y.A.; Kwon H.J.; Bang D.; Lee S.; Sohn S.; Thalidomide upregulates macrophage inflammatory protein-1\u03b1 in a herpes simplex virus-induced Beh\u00e7et\u2019s disease-like animal model. Arch Dermatol Res 2004,296(4),175-181","journal-title":"Arch Dermatol Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejphar.2017.07.022","volume":"813","author":"Choi B.","year":"2017","unstructured":"Choi B.; Sayeed H.M.; Islam S.M.S.; Sohn S.; Role of N-acetyl galactosamine-4-SO4, a ligand of CD206 in HSV-induced mouse model of Beh\u00e7et\u2019s disease. Eur J Pharmacol 2017,813,42-49","journal-title":"Eur J Pharmacol"},{"key":"ref=131","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/690390","author":"Kokturk A.","year":"2012","unstructured":"Kokturk A.; Clinical and pathological manifestations with differential diagnosis in Beh\u00e7et\u2019s disease. Pathol Res Int 2012","journal-title":"Pathol Res Int"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/microorganisms7100429","volume":"7","author":"Koganti R.","year":"2019","unstructured":"Koganti R.; Yadavalli T.; Shukla D.; Current and Emerging therapies for ocular herpes simplex virus type-1 infections. Microorganisms 2019,7(10),429","journal-title":"Microorganisms"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183880","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183880\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T12:30:44Z","timestamp":1696422644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183880\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":132,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020,12,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450121666200719010425","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}